Stephenson, T; Budge, H; (2006) The future of neonatal therapeutic trials. Arch Dis Child Fetal Neonatal Ed , 91 (4) F305 - F307. 10.1136/adc.2005.076802.
Full text not available from this repository.
Neonatology has undoubtedly benefited from clinical trials. Nevertheless, more treatments based on inadequate experimental evidence are given than those that are supported by a validated evidence base. Clinicians seeking the basis for their current and future clinical practice are faced with challenges in the shadow of recent UK legislation and government recommendations. All patients must be protected from inappropriate research, but the benefits of regulations must be appropriately balanced with those of properly conducted clinical trials. It is ethically difficult both to persist with treatments of unproven benefit and unknown harm and to deny infants potentially valuable therapies. It is important that trials are conducted within the new legislative framework, but their future may rest with innovative solutions and the determination of all involved in the process.
|Title:||The future of neonatal therapeutic trials.|
|Additional information:||PMCID: PMC2672739|
|Keywords:||Biomedical Research, Clinical Trials as Topic, Great Britain, Humans, Infant, Newborn, Neonatology|
Archive Staff Only: edit this record